Clavulox® Palatable Tablets

Description:

Broad spectrum beta-lactam antibiotic indicated for many of the commonly seen bacterial infections in dogs and cats.

Recommendations for use:

Skin and soft tissue diseases (e.g. abscesses, superficial and deep pyoderma, anal sacculitis and gingivitis), urinary tract infections, respiratory tract infections (involving upper and lower respiratory tract), enteritis, septicaemia and postparturient infections in dogs and cats.

Pack sizes:

Tablets: 50 & 500 mg – cartons of 100, 250 mg – cartons of 250.

SDS

• Clavulanic acid inactivates ß-lactamases, thus rendering the organisms sensitive to amoxycillin’s rapid effect at concentrations readily attainable in the body.
• In vitro, Clavulox® is active against a wide range of clinically important bacteria, including Gram-positive: Staphylococci (including ß-lactamase producing strains), Corynebacteria spp., Streptococci; Gram-negative: Escherichia coli (including ß-lactamase producing strains), Bordetella bronchiseptica, Proteus mirabilis, Salmonella spp. (including ß-lactamase producing strains), Pasteurella spp. and Klebsiella spp.. This makes Clavulox® a suitable empirical choice for many commonly seen bacterial infections in dogs and cats in general veterinary practice.

Dosage:

A standard dose rate of 12.5 mg/kg bodyweight twice daily is recommended, by oral administration. Refractory cases have shown improved cure rates by doubling the dose to 25 mg/kg bodyweight twice daily. For routine cases continue therapy for 5 to 7 days or for 48 hours after all symptoms have subsided. In chronic or refractory cases a longer course of therapy may be required.

Storage:

Store Below 25°C (Air Conditioning) in a dry place.

The recommended dosage is 12.5 mg/kg of bodyweight twice a day. In routine infections, cats and dogs may be treated for 5 to 7 days or for 48 hours after all symptoms have subsided. Chronic skin diseases may require treatment for 10 to 20 days. Refractory cases, particularly respiratory tract, have shown improved cure rates by doubling the dose to 25mg/kg bodyweight twice daily. These dosage durations are suggested as a guide to treatment.